Singapore markets closed

TScan Therapeutics, Inc. (TCRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.74+0.06 (+0.78%)
As of 03:29PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-89,218
-89,218
-66,221
-48,625
-26,127
Depreciation & amortisation
5,361
5,361
5,137
3,328
1,230
Stock-based compensation
5,208
5,208
4,551
2,516
515
Change in working capital
17,606
17,606
-10,230
-5,896
21,357
Accounts payable
-52
-52
528
10
1,127
Other working capital
-64,504
-64,504
-70,728
-58,618
-7,261
Other non-cash items
757
757
260
-
-
Net cash provided by operating activities
-61,358
-61,358
-66,503
-48,677
-3,023
Cash flows from investing activities
Investments in property, plant and equipment
-3,146
-3,146
-4,225
-9,941
-4,238
Purchases of investments
-77,613
-77,613
0
-
-
Sales/maturities of investments
20,000
20,000
0
-
-
Net cash used for investing activities
-60,759
-60,759
-4,225
-9,941
-4,238
Cash flows from financing activities
Common stock issued
42,414
42,414
193
89,647
0
Other financing activities
-
-
-324
-
-
Net cash used provided by (used for) financing activities
135,443
135,443
29,356
189,668
288
Net change in cash
13,326
13,326
-41,372
131,050
-6,973
Cash at beginning of period
125,064
125,064
166,436
35,386
42,359
Cash at end of period
138,390
138,390
125,064
166,436
35,386
Free cash flow
Operating cash flow
-61,358
-61,358
-66,503
-48,677
-3,023
Capital expenditure
-3,146
-3,146
-4,225
-9,941
-4,238
Free cash flow
-64,504
-64,504
-70,728
-58,618
-7,261